Formycon With Successful 2016 Financial Year
. Group sales grow significantly Development of FYB201 (ranibizumab) and FYB203 (aflibercept) biosimilar projects on…
. Group sales grow significantly Development of FYB201 (ranibizumab) and FYB203 (aflibercept) biosimilar projects on…
. - Revenue up by about 10 percent[1] in the second quarter on a comparable basis - Adjusted EBITDA margin at 17.4 perce…
Due to strong financial results and based on the expectation of ongoing positive prospects for the second half of fin…
. • Sales in the first quarter rise 24% to EUR 257 m (Q1 2016: EUR 208 m) • Company confirms 2017 full-year sales foreca…
- Acquisition of seven companies triggered to drive further expansion of systems competence in both fields of business -…
W1 Forward, Deutschlands erster InsurTech-Accelerator mit Sitz im WERK1 in München, gewinnt mit der ADAC-Schutzbrief Ver…
Industrie 4.0* has been underway for more than five years, and while many businesses have begun some promising Industrie…
. • Siemens’ second-largest bond placement to date • Financing of announced acquisitions and refinancing of outstand…
FAZUA GmbH, the development and distribution firm behind the evation e-bike motor, has successfully completed its Series…
. Siemens Bank receives approval to operate as a merchant bank in Singapore Siemens becomes first industrial compan…